987 related articles for article (PubMed ID: 11907708)
1. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
2. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
[TBL] [Abstract][Full Text] [Related]
3. Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1.
Pedrozo HA; Schwartz Z; Gomez R; Ornoy A; Xin-Sheng W; Dallas SL; Bonewald LF; Dean DD; Boyan BD
J Cell Physiol; 1998 Nov; 177(2):343-54. PubMed ID: 9766531
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD
J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676
[TBL] [Abstract][Full Text] [Related]
5. Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix.
Gay I; Schwartz Z; Sylvia VL; Boyan BD
Biochim Biophys Acta; 2004 Aug; 1684(1-3):18-28. PubMed ID: 15450206
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes.
Pedrozo HA; Schwartz Z; Robinson M; Gomes R; Dean DD; Bonewald LF; Boyan BD
Endocrinology; 1999 Dec; 140(12):5806-16. PubMed ID: 10579347
[TBL] [Abstract][Full Text] [Related]
7. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
Roth-Eichhorn S; Kühl K; Gressner AM
Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
Grainger DJ; Frow EK
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):291-8. PubMed ID: 10926856
[TBL] [Abstract][Full Text] [Related]
10. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
Roth S; Michel K; Gressner AM
Hepatology; 1998 Apr; 27(4):1003-12. PubMed ID: 9537440
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases.
Boyan BD; Schwartz Z
Cells Tissues Organs; 2009; 189(1-4):70-4. PubMed ID: 18765931
[TBL] [Abstract][Full Text] [Related]
12. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase.
Gomez-Duran A; Mulero-Navarro S; Chang X; Fernandez-Salguero PM
J Cell Biochem; 2006 Feb; 97(2):380-92. PubMed ID: 16187295
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
14. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
15. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
Breitkopf K; Lahme B; Tag CG; Gressner AM
Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
[TBL] [Abstract][Full Text] [Related]
16. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
18. Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy.
Tamaki K; Okuda S; Miyazono K; Nakayama M; Fujishima M
Lab Invest; 1995 Jul; 73(1):81-9. PubMed ID: 7603044
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.
Schmitz JP; Schwartz Z; Sylvia VL; Dean DD; Calderon F; Boyan BD
J Cell Physiol; 1996 Sep; 168(3):570-9. PubMed ID: 8816911
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
Budasz-Rwiderska M; Jank M; Motyl T
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
